-
Mitochondrial Transfer in Orofacial Inflammatory Pain
2026-09-16
Li et al. show that satellite glial cells protect trigeminal neurons during acute orofacial inflammation by transferring functional mitochondria through tunneling nanotubes and extracellular uptake. The transferred organelles restore mitophagy and mitochondrial–endoplasmic reticulum contact-site function through ATL1-dependent ER remodeling, linking organelle quality control to neuronal hyperexcitability and pain.
-
Boc-D-FMK: A Practical Pan-Caspase Inhibitor
2026-09-15
Boc-D-FMK helps determine whether experimental cell death is caspase-dependent while also enabling analysis of linked inflammatory signaling. This guide translates product specifications and a recent glioblastoma pharmacology study into practical workflows for renal endothelial, hepatic, and precision-oncology assays.
-
GRE, CREB/MITF, and Anti-Melanogenic Activity
2026-09-15
The reference study evaluates glabridin, resveratrol, and ellagic acid as a combined GRE composition across melanogenesis, oxidative stress, and inflammatory cell models. Its main contribution is linking stronger overall activity with suppression of tyrosinase-associated pigmentation and the CREB/MITF signaling axis, while also identifying experimental limitations relevant to translational pigmentation research.
-
Guanabenz Acetate in GPCR Signaling Research
2026-09-14
Guanabenz Acetate provides a practical α2-adrenergic receptor perturbation tool for connecting subtype pharmacology with cellular stress and innate immune assays. This workflow emphasizes fresh DMSO preparation, receptor-aware dose design, imaging of atypical foci, and careful separation of established findings from exploratory antiviral hypotheses.
-
ATRX Loss and RTK Inhibitor Sensitivity in Glioma
2026-09-14
The reference study identifies ATRX deficiency as a functional vulnerability to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination data with temozolomide support ATRX status as a useful biomarker for interpreting targeted-therapy studies, while also highlighting the need for validation beyond cellular models.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-13
Pairing Cy5 tracking with EGFP expression separates mRNA delivery from productive translation in mammalian cells. This practical workflow shows how to optimize transfection, imaging, flow cytometry, and delivery-system comparisons while avoiding common interpretation errors.
-
LAMP1, CXCL10–CXCR3, and Macrophage Polarization
2026-09-12
The reference study identifies LAMP1-linked autophagy as a molecular switch that determines how the CXCL10–CXCR3 axis regulates macrophage polarization in inflammatory versus non-inflammatory states. By combining pharmacological antagonism, LAMP1 knockdown, and a poly(I:C)-induced lung injury model, the work connects macrophage-state biology with tissue-level inflammatory outcomes.
-
Imidazoline Antagonists and β-Cell K+ Channels
2026-09-12
Jonas, Plant, and Henquin showed that several imidazoline α2-adrenoceptor antagonists stimulate insulin release primarily by inhibiting ATP-sensitive K+ channels in pancreatic β-cells, rather than through adrenergic receptor blockade alone. Their combination of 86Rb efflux, insulin-secretion experiments, and whole-cell patch clamp established a useful framework for separating receptor-mediated effects from direct ion-channel pharmacology.
-
Isorhamnetin Activates PI3K/Akt in Oocyte Maturation
2026-09-11
The reference study shows that Isorhamnetin improves porcine oocyte maturation by activating PI3K/Akt while reducing oxidative stress, apoptosis, mitochondrial dysregulation, and endoplasmic reticulum stress. Its integrated phenotype-to-mechanism design provides a useful framework for studying flavonoid-mediated improvements in oocyte quality and for developing controlled in vitro maturation workflows.
-
Purmorphamine: Reading Smoothened Signaling in Context
2026-09-11
Purmorphamine is a Smoothened agonist for dissecting Hedgehog signaling across osteogenic, stem cell, and sensory models. This evidence-led guide explains how the Apis mellifera Smo study changes assay design, interpretation, and cross-species translation.
-
JHU-083 Workflows for Glutaminase Research
2026-09-10
JHU-083 enables cell-context-focused glutaminase experiments centered on cerebral CD11b cells, glutamate reduction, and disease-relevant neuroinflammation. This workflow pairs its selective pharmacology with layered metabolite, viability, and redox measurements inspired by recent mechanistic toxicology research.
-
Dual-Action Inhibitors and p38α Dephosphorylation
2026-09-10
The reference study shows that some kinase inhibitors do more than block p38α catalytic activity: they also remodel the activation loop to accelerate its dephosphorylation by WIP1. Biochemical assays and X-ray structures connect inhibitor-induced conformational changes with phosphatase accessibility, suggesting a route toward more durable and selective kinase inhibition.
-
MLN4924 HCl Salt for NAE Pathway Studies
2026-09-09
MLN4924 HCl salt enables controlled interrogation of neddylation, cullin-RING ligase activity, protein turnover, and stress-linked cell death. This workflow translates a viral RIPK3-degradation study into practical biochemical, cellular, and inflammation-focused assay designs with built-in controls and troubleshooting guidance.
-
MCC950 sodium: From NLRP3 Signal to Cell Fate
2026-09-09
MCC950 sodium is a selective NLRP3 inflammasome inhibitor for connecting inflammatory signaling with pyroptotic cell injury. This article develops a phenotype-first framework for interpreting macrophage, endothelial, and autoimmune disease experiments.
-
Annexin V-FITC/PI Apoptosis Assay Kit Workflow
2026-09-08
Turn phosphatidylserine externalization and membrane damage into a practical, quantitative cell-death readout with the Annexin V-FITC/PI Apoptosis Assay Kit. This guide connects flow cytometry apoptosis detection to the multi-omics study of processed Rehmannia, while emphasizing controls, tissue-specific handling, and troubleshooting.